According to NGM Biopharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.15 B. In 2022 the company made an earning of -$0.17 B a decrease over its 2021 earnings that were of -$0.13 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.15 B | -12.47% |
2022 | -$0.17 B | 35.18% |
2021 | -$0.13 B | 17.41% |
2020 | -$0.11 B | 139.48% |
2019 | -$42.8 M | 8580.53% |
2018 | -$0.5 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.26 B | 75.95% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.16 M | -87.25% | ๐บ๐ธ USA |